Drug-related problems: An observational study at an Integrated Health Center
Article Sidebar
Main Article Content
Abstract
Failure in drug therapy can cause damage to the patient's health, becoming a real public health problem. The aim of this study was to evaluate a prevalence of DRP in patients of the Integrated Health Center of the University Anhembi Morumbi, São Paulo, Brazil. Medical records of twenty-eight patients were assessed using the Dáder Method from March to September 2019. Gender, age, weight, height, lifestyle and drug therapy were used to profile these patients. The highest concentration of patients aged 54 to 78 years old and the gender profile was 85.2% female and 14.8% male. The proportional ratio was verified when evaluating the profiles of the patients with some report of DRP being, 78.6% female and 21.4% male. The greatest number of prescriptions were observed in neurology and rheumatology, being 50.0% prescriptions of neurology and 32.0% of rheumatology. The specialties with more prescriptions with any identified DRP, with 21.4% were neurology and rheumatology. The DRP1 was the most recurrent in the prescriptions evaluated, followed by DRP5 and DRP6, followed by general practitioner. Further studies are needed to assist in the development of new instruments for the classification and prevention of risks related to medicines, especially in places where there is no pharmacotherapeutic segment, an important practice in reducing medication errors
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Statement - Policy Proposal for Open Access Journals
Authors who publish in The Brazilian journal of Biomedical Sciences (RBCBM) agree to the following terms: 1 - Authors retain the copyright and grant the journal the right to first publication, with the work simultaneously licensed under the Creative Commons Attribution License allowing sharing of the work with recognition of the authorship of the work and initial publication in this journal. 2 - Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal. 3 - Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase the impact and citation of published work.
This is an open access article under the CC-BY license
(http://creativecommons.org/licenses/by/4.0)
References
2. Rodrigues, J. P. V. et al. Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital. PloS One 14, e0210779 (2019).
3. Strand, L. M., Morley, P. C., Cipolle, R. J., Ramsey, R. & Lamsam, G. D. Drug-related problems: their structure and function. Dicp 24, 1093–1097 (1990).
4. Machuca, M., Fernández-Llimós, F. & Faus, M. J. Método Dáder. Guía Seguim. Farmacoter. Granada GIAF-UGR 189–194 (2003).
5. de Consenso, C. Tercer Consenso de Granada sobre problemas relacionados con medicamentos (PRM) y resultados negativos asociados a la medicación (RNM). Ars Pharm. Internet 48, 5–7 (2007).
6. Foppa, A. A., Chemello, C., Vargas-Peláez, C. M. & Farias, M. R. Medication therapy management service for patients with Parkinson’s disease: a before-and-after study. Neurol. Ther. 5, 85–99 (2016).
7. Hayes, B. D., Klein-Schwartz, W. & Barrueto Jr, F. Polypharmacy and the geriatric patient. Clin. Geriatr. Med. 23, 371–390 (2007).
8. Hanlon, J. T., Lindblad, C. I. & Gray, S. L. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults? Am. J. Geriatr. Pharmacother. 2, 3–13 (2004).
9. Sánchez, T. et al. Results of the implementation of a pharmaceutical care programme for patients with multiple sclerosis. Eur J Hosp Pharm 21, 248–250 (2014).
10. Strand, L. M., Cipolle, R. J., Morley, P. C. & Frakes, M. J. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Curr. Pharm. Des. 10, 3987–4001 (2004).
11. Losada-Camacho, M., Guerrero-Pabon, M. F., Garcia-Delgado, P. & Martínez-Martinez, F. Impact of a pharmaceutical care programme on health-related quality of life among women with epilepsy: a randomised controlled trial (IPHIWWE study). Health Qual. Life Outcomes 12, 162 (2014).
12. Hepler, C. D. & Strand, L. M. Opportunities and responsibilities in pharmaceutical care. Am. J. Hosp. Pharm. 47, 533–543 (1990).
13. Marques, L. A. M., Galduróz, J. C. F. & Noto, A. R. Pharmaceutical care to patients treated with antidepressants. Rev. Calid. Asist. 27, 55–64 (2012).
14. Araújo, PS, Costa, EA, Acurcio, FA, et al. Pharmaceutical care in Brazil’s primary health care. Revista de Saúde Pública, 51(Suppl. 2), 6s. Epub November 13, 2017.https://doi.org/10.11606/s1518-8787.2017051007109